These research institutions approximately 3000 around 3000 specialized hospitals and research centers worldwide. BIG is also working with the U.S. National Cancer Institute and the North American collaborative groups with BIG and the North Americans the arena together an impressive integrative power in breast cancer research. To make significant scientific advances in breast cancer research, reduce the wasteful duplication optimally optimally, , the disease, large-scale cooperation is crucial. Therefore BIG facilitates breast cancer research at the international level, Base No.operation between its members and other academic networks and cooperation with, but working independently from, the pharmaceutical industry..
The observation group to treat, ITT) the results of the analysis including all women involved in the study showed a 25 percent reduction in the risk of recurrence in women receiving Herceptin compared to the observation (HR 0, at four years follow-up was nearly 79 percent of women receiving Herceptin cancer-free, a significant increase compared to 73 percent of women in the control group. With respect to safety has been shown that the incidence of severe cardiac dysfunction with adjuvant Herceptin therapy small was (0, these results confirm the benefits and safety of one year treatment with Herceptin in women with HER2-positive tumors despite the substantive crossover of patients from the observation group, active treatment.The research project is Tushara Tushara Wickramariyaratne on the Department of Psychology at ANU. It aims to to shed light on are many unanswered questions about the challenges of Australian is available as the multicultural country in his efforts to to shed its aging population needs.